If you’re interested in joining our group, please get in touch.
Professor Emeritus
Reidar Albrechtsen
I am a specialist in pathology and cytology since 1976, have worked for several years as a clinical
pathologist at the Department of Pathology, Rigshospitalet, and served as professor emeritus at BRIC since 2018. My research is focused on the the field of pathology and cell biology, where I have and still am contributing with DNA sequencing, production of monoclonal and polyclonal antibodies and expression studies of several proteins including laminin, tetranectin, and ADAM12.
Postdoctoral scientists
Kamilla Westarp Zornhagen
During my PhD I studied the tumour microenvironment and its heterogeneity in spontaneous canine soft tissue sarcomas using different molecular markers. Now my research is focused on the extracellular matrix (ECM) and how it affects metastasis.
The past few years I have worked with translation research, ADAMs, the tumor microenvironment, organoids, and circulating tumor cells, which will also be my research focus here at BRIC.
Victor Oria
I am intrigued by the tumor microenvironment; specifically how cancer cells hijack the vascular system to their benefit. My current research investigates how tumor-driven angiocrine signaling feeds back on the growing tumor to drive loco-vascular invasion and subsequent metastasis.
Kasper J. Mygind
I have worked on protein maturation and transport in cells, more
specifically how proteins exit the ER and are transported into the Golgi apparatus. To this end I have worked on small GTPases involved in Golgi integrity. I am currently focused on two research areas, first genome modulation (knock-out and knock-in) to study endogenous gene functions. Here I have developed a library of reporter cells enabling us to study protein function as well as cell-cell interactions in vitro and in vivo. Second research area is understating how soluble Basigin / CD147 are pro-tumorigenic
Ph.D. students
Joana Leitão Castro
My research aims to understand the cellular communication between cancer cells and cancer associated fibroblasts (CAFs), as well as to unravel the molecular mechanism by which cancer cell-derived ADAM12 activates the tumor stroma and promotes ECM production. Overall, my goal is to identify new strategies to limit the desmoplastic response as a way to improve cancer treatments.
Guangzheng Weng
I’m a Ph.D. student at BRIC. My research interest is about single-cell RNA-sequencing and machine learning applied on large-scale biological data analysis. Now I’m focusing on spatial transcriptomics.
Alumni
Adina Jensen
Alejandro Mayorca Guiliani
Amro Ashmawy
Andreas Hadjiprocopis
Anette Høye
Ann-Marie Baker
Anna Leibold
Anu Laitala
Christine J
Demelza Bird
Dina Grønseth
Dorte Lauritsen
Fabian Schmich
Freia Isak Jørgensen
Freja Venning
Georgina Lang
Giorgia Maltese
Helen Frost
Holly Barker
Jan Strøbech – Advanced Quality Supply Professional at Novo Nordisk (Denmark)
Jesper Thorhauge Pedersen
Joan Chang
Lara Perryman
Lena Wullkopf
Lidia Leonte
Louis Jensen
Lukram Babloo Singh
Marc Garcia Montolio
Maria Rafaeva
Marie-Claude Djidja
Marina Crespo Bravo
Martina Mrsnik
Ninna Rossen
Oliver Willacy
Peter Bavngaard Thrane
Pier Giorgio Amendola
Pietro Giuriatti
Raphael Reuten
Rikke Stagaard – Study director at Minerva Imaging (Denmark)
Sebastian R. Nielsen
Sofie Dahl Tolstrup
Tian Xia
Tine Thurison Røndbjerg
erlerlab 